Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas

Table 2

Percentages of E-cadherin and syndecan-1 expression and their relationship with the clinical parameters.

Expression, versus	Gender (SD)	Mean age, years (SD)	Maxilla and mandible (SD)	Radiographic pattern (SD)	Tumoral size, cm (SD)	Recurrence (SD)
	Male/female	<30.4/≥30.4	Anterior/posterior	Unilocular/multilocular/unknown	<5.3/≥5.3	Yes/no
% Ecad	61.1 ± 26.7/52.7 ± 32.6	60.4 ± 30.1/53.4 ± 28.8	Maxilla: 85± 7.1/60; Mandible: 70± 10/56.4 ± 30.1	57.6 ± 32/54.5 ± 27.3/62.8 ± 23.9	55.2 ± 30.4/61.3 ± 28	57.1 ± 26.2/57.5 ± 29.9
% Syn1E	59.6 ± 24.9/54.7 ± 26.9	56.5 ± 26.7/58.9 ± 24.8	Maxilla: 55± 21.2/70; Mandible: 63.3 ± 20.8/57.3 ± 26	57.5 ± 26.2/58.9 ± 25.3/55± 26.1	55± 26.6/62± 24.1	47.1 ± 33/58.3 ± 25.2
% Syn1S	47.8 ± 27.8/43.9 ± 28.1	40.3 ± 28.3/54± 25.6	Maxilla: 20± 28.3/30; Mandible: 41.7 ± 36.2/46.9 ± 27.8	41.3 ± 26.7/52.9 ± 27.7/48.4 ± 29.9	46± 28.1/46.2 ± 27.9	44.3 ± 32.6/46.2 ± 27.7
p =	0.651	0.424	0.690	0.104	0.049	0.027

Kurskal-Wallis test, significance at . Statistical significance was found between the percentage expression and tumoral size and recurrence. Ecad = E-cadherin expression; Syn1E = epithelial expression of syndecan-1; Syn1S = stromal expression of Syndecan-1.